Company profile ARDX

Ardelyx Inc
ardelyx is focused on enhancing the way people with renal diseases are treated by developing first-in-class medicines. ardelyx's renal pipeline includes the phase 3 development of tenapanor for the treatment of hyperphosphatemia in people with end-stage renal disease who are on dialysis and rdx013, a potassium secretagogue program for the potential treatment of high potassium, ...or hyperkalemia, a problem among certain patients with kidney and/or heart disease. in addition, ardelyx has completed phase 3 development of tenapanor for the treatment of irritable bowel syndrome with constipation and anticipates submitting a new drug application to the u.s. food and drug administration for this indication in the second half of 2018. to efficiently bring its treatments to market, ardelyx is pursing strategic collaborations in the u.s. and other countries, including through established agreements with kyowa hakko kirin in japan, fosun pharma in china and knight therapeutics in canada. Show More
Quarter analysis & expected interestLast update: February 08 2024 15:12:27.

After 39 days of this quarter the interest is at 124.0. Based on that we can calculate that during remaining 52 days it will total up to 289.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201929
39
34.5% QoQ
188
382.1% QoQ
109
-42.0% QoQ
2020 134
362.1% YoY 22.9% QoQ
121
210.3% YoY -9.7% QoQ
139
-26.1% YoY 14.9% QoQ
120
10.1% YoY -13.7% QoQ
2021 180
34.3% YoY 50.0% QoQ
246
103.3% YoY 36.7% QoQ
329
136.7% YoY 33.7% QoQ
215
79.2% YoY -34.7% QoQ
2022 137
-23.9% YoY -36.3% QoQ
188
-23.6% YoY 37.2% QoQ
125
-62.0% YoY -33.5% QoQ
280
30.2% YoY 124.0% QoQ
2023 252
83.9% YoY -10.0% QoQ
208
10.6% YoY -17.5% QoQ
249
99.2% YoY 19.7% QoQ
378
35.0% YoY 51.8% QoQ
2024 124
-50.8% YoY -67.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ardelyx search interestLast update: February 08 2024 15:12:27.
Correlation coefficient between keyword and revenue is 0.44
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:12:29.

The average 5 years interest of Ardelyx was 14.52 per week.
The last year interest of Ardelyx compared to the last 5 years has changed by 44.49%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 167.94%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Ardelyx medicines to provide analysis

Correlation between past revenue and Ardelyx medicines search interest

There is not enough data for Ardelyx medicines to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Ardelyx medicines to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 03 2023 17:21:30.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
300
inf% YoY inf% QoQ
298
inf% YoY -0.7% QoQ
2021 234
inf% YoY -21.5% QoQ
356
inf% YoY 52.1% QoQ
317
5.7% YoY -11.0% QoQ
169
-43.3% YoY -46.7% QoQ
2022 168
-28.2% YoY -0.6% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2023 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Tenapanor search interestLast update: November 03 2023 17:21:30.
Correlation coefficient between keyword and revenue is -0.28
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 03 2023 17:21:30.

The average 5 years interest of Tenapanor was 7.06 per week.
The last year interest of Tenapanor compared to the last 5 years has changed by -100.0%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Ardelyx irritable bowel syndrome to provide analysis

Correlation between past revenue and Ardelyx irritable bowel syndrome search interest

There is not enough data for Ardelyx irritable bowel syndrome to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Ardelyx irritable bowel syndrome to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 15:12:34.

After 39 days of this quarter the interest is at 161.0. Based on that we can calculate that during remaining 52 days it will total up to 376.0.
XPHOZAH expected interest is significantly higher compared to same quarter last year (+516.4%) but similar to previous quarter.

YearQ1Q2Q3Q4
201916
61
281.2% QoQ
15
-75.4% QoQ
60
300.0% QoQ
2020 53
231.2% YoY -11.7% QoQ
31
-49.2% YoY -41.5% QoQ
28
86.7% YoY -9.7% QoQ
138
130.0% YoY 392.9% QoQ
2021 59
11.3% YoY -57.2% QoQ
156
403.2% YoY 164.4% QoQ
65
132.1% YoY -58.3% QoQ
49
-64.5% YoY -24.6% QoQ
2022 105
78.0% YoY 114.3% QoQ
58
-62.8% YoY -44.8% QoQ
0
-100.0% YoY -100.0% QoQ
51
4.1% YoY inf% QoQ
2023 61
-41.9% YoY 19.6% QoQ
103
77.6% YoY 68.9% QoQ
213
inf% YoY 106.8% QoQ
363
611.8% YoY 70.4% QoQ
2024 161
163.9% YoY -55.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and XPHOZAH search interestLast update: February 08 2024 15:12:34.
Correlation coefficient between keyword and revenue is -0.03
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:12:35.

The average 5 years interest of XPHOZAH was 7.07 per week.
The last year interest of XPHOZAH compared to the last 5 years has changed by 139.04%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 478.77%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RDX013 to provide analysis

Correlation between past revenue and RDX013 search interest

There is not enough data for RDX013 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RDX013 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RDX020 to provide analysis

Correlation between past revenue and RDX020 search interest

There is not enough data for RDX020 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RDX020 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 03 2023 17:22:27.

After 34 days of this quarter the interest is at 17.0. Based on that we can calculate that during remaining 58 days it will total up to 46.0.
Ardelyx stock price expected interest is significantly lower compared to previous quarter (-56.2%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 122
2019 21
-82.8% QoQ
144
585.7% QoQ
24
-83.3% QoQ
74
-39.3% YoY 208.3% QoQ
2020 57
171.4% YoY -23.0% QoQ
127
-11.8% YoY 122.8% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2021 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2022 0
-100.0% YoY -100.0% QoQ
40
inf% YoY inf% QoQ
21
inf% YoY -47.5% QoQ
34
inf% YoY 61.9% QoQ
2023 74
inf% YoY 117.6% QoQ
176
340.0% YoY 137.8% QoQ
105
400.0% YoY -40.3% QoQ
17
-50.0% YoY -83.8% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ardelyx stock price search interestLast update: November 03 2023 17:22:26.
Correlation coefficient between keyword and revenue is 0.15
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 03 2023 17:22:27.

The average 5 years interest of Ardelyx stock price was 3.97 per week.
The last year interest of Ardelyx stock price compared to the last 5 years has changed by 96.73%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 30.6%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Ardelyx clinical trials to provide analysis

Correlation between past revenue and Ardelyx clinical trials search interest

There is not enough data for Ardelyx clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Ardelyx clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Ardelyx jobs to provide analysis

Correlation between past revenue and Ardelyx jobs search interest

There is not enough data for Ardelyx jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Ardelyx jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ARDX
Earnings date: 2024-02-22 After close
Company name: Ardelyx Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-07T12:01:00Z

GlobeNewswire
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF's Spring Clinical Meetings

2026-04-30T20:01:00Z

GlobeNewswire
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update

2026-04-27T12:01:00Z

GlobeNewswire
Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF's Spring Clinical Meetings

2026-04-23T12:01:00Z

GlobeNewswire
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

2026-04-20T12:00:00Z

GlobeNewswire
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

2026-04-16T12:01:00Z

GlobeNewswire
Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026

2026-04-01T12:01:00Z

GlobeNewswire
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

2026-03-09T20:05:00Z

GlobeNewswire
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C

2026-03-04T13:00:00Z

GlobeNewswire
Ardelyx to Participate in Upcoming Investor Conferences

2026-02-24T13:00:00Z

GlobeNewswire
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions

2026-02-23T13:29:45Z

Analyst Upgrades
Wedbush Reiterates Outperform on Ardelyx, Maintains $19 Price Target

2026-02-20T11:39:59Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Ardelyx, Raises Price Target to $18

2026-02-20T10:09:57Z

Analyst Upgrades
BTIG Reiterates Buy on Ardelyx, Maintains $17 Price Target

2026-02-19T21:01:00Z

GlobeNewswire
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

2026-02-05T13:00:00Z

GlobeNewswire
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026